Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02054468Completed
Randomised, open-label trial of rocuronium, sponsored by Technical University of Munich. Primary endpoints: Effective Dose 50 at 180 minutes and Effective Dose 95 at 180 minutes. Started Mar 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02054468.